Literature DB >> 7164166

Trypanosoma brucei rhodesiense infection in vervet monkeys. I. Parasitologic, hematologic, immunologic and histologic results.

H Schmidt, P Sayer.   

Abstract

Twenty vervet monkeys infected with T. rhodesiense (Eatro 1989) developed chronic disease with an average duration of 65 days (variation 35-107 days). With respect to the course of the disease, and to the hematologic, immunologic and histological findings, the disease faithfully mirrored human T. rhodesiense infection. In all animals, parasitization of the CSF occurred only a few weeks after infection, and was accompanied by an increase in the cell count and the appearance of IgM in the CSF. The main histopathological feature was severe pancarditis which was responsible for death in almost all animals. Chronic leptomeningitis resulted as histological substrate of the early parasitosis of the CSF. In most animals meningitis was accompanied by a mitigated encephalitic early reaction characterized by sparse lymphoplasmocytic infiltrates, exclusively of the cerebral vessels, with a predilection for the base of the brainstem and the neighbourhood of the ventricles. Autonomous meningoencephalitis with parasites in the brain tissue was found in only one animal (with the longest survival period of 107 days). In view of the regular parasitosis of the CSF, T. rhodesiense infection of the vervet monkey may be considered a suitable animal model for the assessment of the liquor "uptake" of trypanocidal drugs.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7164166

Source DB:  PubMed          Journal:  Tropenmed Parasitol        ISSN: 0303-4208


  3 in total

1.  African trypanosomiasis: haematogenic brain parasitism early in experimental infection through bypassing the blood-brain barrier, with considerations on brain trypanosomiasis in man.

Authors:  H Schmidt; J M Bafort
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

2.  Chemotherapy of second stage human African trypanosomiasis: comparison between the parenteral diamidine DB829 and its oral prodrug DB868 in vervet monkeys.

Authors:  John K Thuita; Kristina K Wolf; Grace A Murilla; Arlene S Bridges; David W Boykin; James N Mutuku; Qiang Liu; Susan K Jones; Charles O Gem; Shelley Ching; Richard R Tidwell; Michael Z Wang; Mary F Paine; Reto Brun
Journal:  PLoS Negl Trop Dis       Date:  2015-02-05

3.  Delineating neuroinflammation, parasite CNS invasion, and blood-brain barrier dysfunction in an experimental murine model of human African trypanosomiasis.

Authors:  Jean Rodgers; Barbara Bradley; Peter G E Kennedy
Journal:  Methods       Date:  2017-06-19       Impact factor: 3.608

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.